Can Acceptable Hla Mismatches Be Predicted
Even with the large number of prospective donors listed by the various registries around the world, many patients do not find a matched donor even for HLA-A, -B, -C, -DRB1 . Despite the increased risk associated with HLA-mismatched transplants, acceptable results are achieved for many patients despite an imperfectly matched donor. The question raised is whether certain HLA mismatches are better tolerated than others and if so, whether this can be applied to donor selection to improve outcome....
Summary Eal
The myelodysplastic syndromes are heterogeneous clonal stem cell disorders characterized by dysplastic pathological features, clinical peripheral cytopenias, and a tendency to progress to AML. The pathogenesis of MDS includes clonal gene function alterations due to single-gene alteration, chromosomal abnormalities or epigenetic phenomenon. Apoptosis can explain the paradoxical observation of peripheral cytopenias and normo- or hypercellular bone marrow. Different mechanisms, such as abnormal...
Idarubicin For Myeloma
32. Monconduit M, Menard JF, Michaux JL, et al. VAD or VMBCP in severe multiple myeloma. The Groupe d'Etudes et de Recherche sur le Myelome GERM . Br J Haematol 80 2 199-204, 1992. 33. Barlogie B, Kyle RA, Anderson KC, et al. Comparable survival in multiple myeloma MM with high dose therapy HDT employing MEL 140 mg m2 TBI 12 Gy autotransplants versus standard dose therapy with VBMCP and no benefit from interferon IFN maintenance results of intergroup trial S9321. Session type oral session...
Info Smz
LDH, lactate dehydrogenase CNS, central nervous system. LDH, lactate dehydrogenase CNS, central nervous system. intrathecal therapy or prophylaxis. Despite this, some groups continue to use radiation therapy, although at reduced doses, as a component of CNS prophylaxis or treatment.63 No agreed standard of care exists for the initial treatment of BL. Most regimens in common use have features as described above. Results of these regimens have improved progressively over the last 20 years....
Stem cell in vitro purging
As stated at the outset of this chapter, due to the nature of harvesting stem cells in a marrow disorder such as leukemia, one can expect tumor contamination of grafts. A number of approaches to reduce tumor burden among harvested grafts have been undertaken to reduce the likelihood of relapse following ASCT. Such relapses can be expected to arise from one of the two sources harvested cells in the autograft, or unharvested, drug-resistant clones that survive the preparative regimen. A...
Farnesyltransferase inhibitors
The ras oncogene is positioned at the crossroads of cellular signaling pathways, and its role in the neo-plastic process is well appreciated.34 35 Mutations in codons 12, 13, or 62 of ras significantly affect its physiological role and result in a permanently activated state, causing dysregulated proliferation. CMML is the hematologic malignancy with the highest frequency of ras mutations in the largest reported cohort of patients, the prevalence of the N-ras and K-ras mutations was 38 ,4 and...
Do Patients With Primary Refractory Disease Have A Suboptimal Outcome With Asct
While response to SC is the major selection criteria to proceed to ASCT, other prognostic factors also predict for long-term FFTF in patients with relapsed and refractory HL. Some groups have suggested that patients with primary refractory disease do less well than those patients who achieve an initial remission to front-line therapy. There are conflicting registry data in this regard. The North American Autologous Blood and Bone Marrow Transplant Registry ABMTR reported on a series of 122...
Blood And Bone Marrow Changes
Anemia is present in 60-80 of patients at presentation.1-5 It is usually mild to moderate in severity and is normocytic, normochromic in morphology. The anemia has the characteristics of anemia of chronic inflammation formerly anemia of chronic disease with low serum iron, decreased transferrin saturation, and elevated ferritin. The reticulocyte count is low, reflecting a hypoproliferative state. A bone marrow examination commonly reveals erythroid hypoplasia and a varying degree of myeloma...
Therapy of relapse DLI and imatinib
ALL in relapse after transplantation is rarely salvaged by donor lymphocyte infusion. This observation is consistent but confusing, since there does appear to be a measurable GVL response in primary transplantation. Less than 20 of patients will achieve a remission to DLI alone52,53 however, this number may be increased with concomitant chemotherapy. Despite this, remissions are rarely durable. Imatinib has been used as therapy for relapse after transplantation of ALL54 however, the majority of...
Info Kdu
63. Robbins DH, Margulies I, Stetler-Stevenson M, Kreitman RJ Hairy cell leukemia, a B-cell neoplasm which is particularly sensitive to the cytotoxic effect of anti-Tac Fv -PE38 LMB-2 . Clin Cancer Res 6 693-700, 2000. 64. Kreitman RJ, Pastan I Targeted toxin hybrid proteins. In Oxender D, Post LE eds. Novel Therapeutics from Modern Biotechnology. Berlin Germany Springer-Verlag 1997 89-110. 65. Buchner J, Pastan I, Brinkmann U A method for increasing the yield of properly folded recombinant...
Introduction Dgi
Most of the 15,000 people per year in the United States who develop multiple myeloma MM 1 require some form of treatment at the time of diagnosis. Combination regimens incorporating alkylating agents, corticosteroids, and or anthracyclines have been used for decades, with little overall progress during that time in terms of survival or cure rate.2' 3 High-dose chemotherapy with autologous stem cell support HDC ASCS , shown in some studies to offer a modest survival benefit, is nonetheless...
Emanuele Zucca
The term marginal zone lymphoma MZL is believed to be derived from B cells normally present in the marginal zone and was proposed in the Revised European-American Lymphoma REAL classification1 to take account of three apparently related lymphoma subtypes, namely the extranodal low-grade B-cell lymphoma of mucosa-associated lymphoid tissue MALT usually named MALT lymphoma, the nodal monocytoid B-cell lymphoma, and the primary splenic MZL with or without villous lymphocytes. At that time, the...
Info Amw
Stanford City of Hope37 69 CR1 TBI VP CY or 50 74 5 2002 gt CR1 CBV 21 51 5 French multicenter38 2 3 Newly diagnosed CHOP DHAP 83 90 3 FHCRC39 16 Relapsed CY tositumomab 61 93 3 2002 PFS EFS progression-free survival event-free survival OS overall survival CHOP cyclophosphamide, doxorubicin, vincristine, prednisone CBV cyclophosphamide, carmustine, etoposide EBMT European Bone Marrow Transplant Group CR1 first complete remission BEAM car-mustine, etoposide, cytarabine, melphalan BEAC...
Aggressive Transformation
There is much confusion about aggressive transformation in chronic lymphocytic leukemia CLL . Unlike chronic myeloid leukemia where such a transformation is the rule, in CLL it is rare. Moreover, transformation to acute lymphoblastic leukemia ALL , although reported in the literature,1 is a myth based on a misunderstanding of the nature of CLL. We can, however, recognize different ways in which CLL can transform Table 27.1 . In 1928, Maurice Richter described an aggressive lymphoma occurring in...
Cytologyhistopathology
The key diagnostic feature of CLL relies on a careful examination of the peripheral blood smear. In a typical case, there is a lymphocytosis of small, round, mature-appearing lymphocytes with scant amounts of cytoplasm and mature chromatin. Typically, the chromatin has a characteristic clumped appearance with absent nucleoli. Disrupted lymphocytes, known as smudge cells, are a common finding in CLL Figure 22.1 . A lym-phocytosis of 5 X 109 lymphocytes L has been a mandatory part of the...
Info Chw
118. Muller GW, Chen R, Huang SY, et al. Amino-substituted thalidomide analogs potent inhibitors of TNF-alpha production. BioorgMed Chem Lett 9 11 1625-1630, 1999. 119. Corral LG, Haslett PA, Muller GW, et al. Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha. J Immunol 163 1 380-386, 1999. 120. Richardson PG, Schlossman RL, Weller E, et al. Immunomodulatory drug CC-5013 overcomes drug resistance and...
Deletion Of Chromosome 13q
Deletion of chromosome 13q is the most common recurrent chromosomal abnormality in myeloma. It is detected in 15-20 of myeloma by CC,21 50 of cases by interphase FISH in newly diagnosed myeloma patients,22 and 30-45 of cases of MGUS.23'24 The prognostic significance of loss of 13q identified by FISH alone has been the subject of considerable debate. Several studies based on molecular cytogenetics have shown that this abnormality is strongly associated with an unfavorable prognosis.2325-32 It...
Monoclonal Antibodies For Treatment Of Classical Hodgkins Lymphoma
Among the different target antigens on Reed-Sternberg cells, CD30 seems to be the most promising, since it is expressed at very high levels.75 So far, two anti-CD30 MoAbs have been developed, the humanized SGN-3076 and the fully human MDX-60.77The SGN-30 chimeric anti-CD30 antibody has demonstrated antitumor activity in preclinical models of Hodgkin's lymphoma and anaplastic large cell lymphoma. In a phase I single-dose trial, SGN-30 MoAb showed minimal toxicity with doses from 1 to 15 mg kg,...
Epidemiology Lxj
CLL is the most common adult form of leukemia in Western society. According to a recent analysis of the Surveillance Epidemiology and End Results database,1 the annual overall age-adjusted incidence in the United States between 1997 and 2001 was 3.5 100,000 people 5.0 100,000 for males and 2.5 100,000 for females. This is a disease of older adults with distinct and unique clinical characteristics and concerns. The majority of individuals are diagnosed when over 65 years of age, and the...
Matrix metalloprotease inhibitors MMPis
These compounds result in antiangiogenesis by inhibiting the matrix metalloproteases zinc-dependent endopeptidases of the extracellular matrix, thereby altering integrin-mediated cell adhesion. MMPis also promote local release of the proteoglycan- membrane -bound forms of VEGF, TNFa, and soluble Fas ligand. AG3340 is a potent, oral selective MMPi. AG3340 Prinomastat was administered to 34 MDS patients of all subtypes in a phase II multicenter randomized trial.51 Patients were given either 5 mg...
The Morphologic Diagnosis Of Multiple Myeloma
The morphologic diagnosis of multiple myeloma and its distinction from reactive plasmacytosis relies on both the quantity of plasma cells seen and the qualitative plasma cell abnormalities, as previously mentioned. In general terms, more than 30 of plasma cells in a marrow aspirate smears constitute a major diagnostic criterion for multiple myeloma, although such a percentage may occur in other conditions, such as rheumatic disorders, inflammatory reactions of the bone marrow, and in...
Aml Transplant Prognosis
Although many clinical and pathologic features of AML have prognostic relevance, only a few prognostic factors are universally agreed upon, validated, and impact clinical practice. Nonetheless, newer biologic markers of prognosis are likely to supplant older clinical markers in the near future. As discussed further, and in greater detail in Chapter 5, age greater than 60 years invokes many adverse features that make separation of age from other poor prognostic markers difficult. Nonetheless,...
Future Directions In Therapy For Advancedphase Cml
The success of imatinib will clearly result in fewer patients with CML progressing to the advanced phases. Is blastic phase CML a disease of the past Further observational time will let us know what percent of patients with CML will be cured with imatinib. Although leukemia cells resistant to imatinib have been detected in patients with CML, this has mostly occurred in advanced-phase patients who received imatinib for the first time, having received prior treatment with other agents.47 The...
Hematogones
Occasionally it is difficult to distinguish between persistent disease and the presence of hematogones.2-4 Hematogones are nonmalignant lymphoid progenitor cells found in the bone marrow, and are similar to lymphoblasts. Hematogones are usually heterogenous in size and are nonclonal. If the ALL blasts express myeloid markers, the hematogones, by definition, are devoid of these and therefore can be distinguished from leukemia blasts. If the hematogones do not express myeloid markers, it is...
Extramedullary Involvement
More uncommonly, patients present with symptoms secondary to leukemic infiltration of various tissues, leading to hepatomegaly, splenomegaly, leukemia cutis 2-10 of patients , gingival involvement, tumorous nodules myeloid sarcoma 3-5 of patients , lymphadenopathy, bone, or central nervous system CNS involvement 1 of patients .3'5 Occasionally, patients may present with pericardial effusions.2 Pulmonary infiltrates may also represent leukemia. Leukemic infiltrates in the lungs occur more...
Myelodysplastic Syndrome Mds And Acute Myeloid Leukemia Aml Incidence And Risk
Historically, myelodysplastic syndrome MDS and secondary acute myelogenous leukemia have been recognized as significant complications of alkylating-agent-based chemotherapy for both indolent NHL and Hodgkin's lymphoma.1112 Topoisomerase inhibitors13 and purine analogs14 also clearly contribute to the risk of AML and MDS. With the recent introduction of alternative chemotherapy and immunotherapeutic modalities, autologous stem cell transplantation ASCT and radioimmunotherapy represent the...
Overexpression Of The Baalc Gene
The BAALC gene, mapped to band 8q22.3, encodes a protein with no homology to any known proteins or functional domains. BAALC is expressed mainly in neu-roectoderm-derived tissues and hematopoietic precursors, with no expression in mature BM or blood mononuclear cells.65 High expression of BAALC mRNA in circulating blasts is an independent adverse prognostic factor in uniformly treated adults younger than 60 years with de novo AML and normal cytogenetics.1920 In another, smaller study, high...
Laboratory Abnormalities In Hyperleukocytosis
Pseudohyperkalemia can be present in patients with a high white blood count secondary to breakdown of white cells in vitro with subsequent release of potas-sium.2 Other spurious laboratory data that can be seen in association with hyperleukocytosis include a falsely elevated platelet count secondary to white cell fragments , pseudohypoxemia secondary to oxygen consumption by leukocyte cells , falsely prolonged coagulation tests, and pseudohypoglycemia.421-24 Pseudohypoxemia and...
References Jvm
1. Jemal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 53 5-26, 2003. 2. Chiu BC, Weisenburger DD An update of the epidemiology of non-Hodgkin's lymphoma. Clin Lymphoma 4 161-168, 2003. 3. Groves FD, Linet MS, Travis LB, et al. Cancer surveillance series non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J Natl Cancer Inst 92 1240-1251, 2000. 4. Diebold J, Anderson JR, Armitage JO, et al. Diffuse large B-cell lymphoma a...
Info Qwj
Two relapses after allo SCT alive at 13 and 41 months after salvage chemotherapy PFS, progression-free survival OS, overall survival VP, etoposide BM, bone marrow PB, peripheral blood TRM, treatment-related mortality occuring in the first year after transplant CR, complete remission NS, not stated specifically Dexa-BEAM, aTwo patients received nonmyeloablative allo SCT. PFS, progression-free survival OS, overall survival VP, etoposide BM, bone marrow PB, peripheral blood TRM, treatment-related...
IMMUNE STIMULATION AND MYELOMA Chronic infections and eczema
Many medical conditions associated with chronic stimulation of the immune system, such as repeated infections, allergic conditions, or autoimmune disease, have been reported to increase the risk of MM. In a case-control study, past history was abstracted from medical records for leukemia, n 299 non-Hodgkin's lymphoma NHL , n 100 and MM, n 175 patients, and matched with 787 controls. Prior histories of eczema and musculoskeletal conditions were associated with higher risk for MM with no role...
Cytogenetics
Leukemic blasts of the majority of patients with AML at diagnosis carry at least one clonal chromosome abnormality, i.e., an identical structural aberration or gain of the same, structurally intact chromosome trisomy found in at least two metaphase cells or the same chromosome missing monosomy from a minimum of three cells. Abnormal karyotypes are more frequent in children with de novo AML, being detected in 70-85 of patients compared with 55-60 of adults.8-13 Therapy-related secondary AML is...
Targeting Cd52 On Hcl Cells With Alemtuzumab
CD52 is a 12-amino-acid glycoprotein that is present on lymphocytes at up to 450,000 sites cell.48'49 It is also present on monocytes, macrophages, eosinophils, and the male reproductive tract.5051 Quigley et al. at the Scripps Clinic recently reported that in nine cases of classic HCL and one of HCLv, all patients expressed CD52 on 92-100 of the HCL cells.52 Fietz et al. reported recently that a patient with HCL and shortlived or poor responses to cladribine, interferon, splenectomy, and...
Differential Diagnosis 1
A malignant lymphoproliferative disorder should be suspected when the absolute lymphocyte count is greater than 5000 lymphocytes L. The differential diagnosis for patients with lymphocytosis, lym-phadenopathy, and or organomegaly includes numerous malignant lymphoproliferative disorders Table 23.1 . These include CLL, PLL, adult peripheral T-cell lymphoma, natural killer cell leukemia, mantle cell lymphoma, marginal zone lymphoma nodal, extran-odal, or splenic , hairy cell leukemia, SLL,...
With Bcrablderived Peptide Vaccines
As discussed above, many clinicians still consider allo-geneic stem cell transplantation to be the gold standard for curative therapy in CML by virtue of the long-term survival achieved and the ability of this modality to render the patient BCR ABL negative using PCR-based assays. The importance of the immunologic properties of the graft has received a great amount of attention, with attempts to recapitulate a GvL effect while separating it from the side effects of conventional transplantation...
Classification Jld
The classification of CMPDs is based on the lineage of the predominant proliferating cells and the prominence of marrow fibrosis, taken together with a constellation of clinical and laboratory features. The World Health Organization WHO classification system6 identifies seven conditions under the category of CMPDs, as shown in Table 45.1. Tefferi9 classified ET, PV, and IMF as CPMDs. The CMPDs, in turn, are members of a broader class of Table 45.1 WHO classification of chronic...
Treatment Of Small And Mediumsized Pleomorphic Tcell Lymphoma And Cd30 Large
Patients with CD30 LTCL or small medium-sized PTCL usually present with solitary, localized, or generalized plaques, nodules, or tumors without spontaneous regression.96 Both entities do not express CD30 with absence of a Th2 cytokine profile in CD30 LTCL.97 In CD30- LTCL, large cells comprise over 30 of the dermal infiltrate and might resemble classical MF undergoing large cell transformation. Multiagent systemic chemotherapy is recommended in most cases, with radiotherapy limited to localized...
Cd5 B Cells And The Possible Role Of Clonal Lymphocytes Of Unknown Significance
CLL is a disease of CD5 B cells. CD5 is a highly conserved single-chain 67-kDa transmembrane glycoprotein containing three scavenger receptor cysteine-rich SRCR domains. CD5 expression is found on all human T cells, but only on a subset of B cells. Despite its sequence conservation, CD5 expression in T cells and B cells varies widely from species to species in some, all B cells are CD5 positive. Studies on CD5-deficient mice have shown that CD5 functions as a negative regulator of B-cell...
Karl S Theil MD
Staff Pathologist, The Cleveland Clinic Foundation Cleveland, Ohio Bing Program for Waldenstr m's Macroglobulinemia Dana Farber Cancer Institute, Boston, Massachusetts Director, Stem Cell Transplantation and Lymphoma Section of Hematology Oncology, Department of Medicine Division of Biological Sciences, The University of Chicago Chicago, Illinois Departments of Hematology and Medical Oncology and Clinical Pathology, The Cleveland Clinic Foundation Cleveland, Ohio
Microarray Analysis In Mds
The introduction of microarray analysis revolutionized the analysis of gene profiles. Not only can thousands of genes be analyzed together, but the technique also identifies gene profiles, molecular signatures that can help refine the disease, categorize its subtypes, better predict outcomes, and hopefully tailor therapies. Microarray analysis studies in MDS identified new important genes, profiles that may help distinguish MDS from AML, as well as low risk from high risk MDS. In one study,...
Agriculture
Agricultural work predominantly farming is an occupation that has been most frequently associated with MM.81 Early reports from Iowa farmers in the 1970s showed a significantly higher mortality rate for MM and leukemia.82 A recent update of these data suggest that association between farmers and MM is weaker than initially reported.983 84 Similar results were reported from Sweden. There were 568 MM cases among 254,417 men working in agriculture, with an estimated RR of 1.20 95 CI 1.09-1.33 .85...
Other chemotherapeutic agents
Not much is known about the effectiveness of other cytoreductive agents in managing CMML as assessed in phase I II trials. For example, three separate studies with the anthracycline idarubicin suggested that it has limited activity, with no significant responses observed in CMML patients who were treated daily with intermediate dosages.1112 In the first trial of oral etoposide VP-16 , 10 consecutive patients with CMML were treated with 100 mg of etoposide orally, daily for 3 days 50 mg in...
Comparisons Of Allo Sct Versus Auto Sct Intermediateand Highgrade Nhl
Table 65.6 shows a number of publications comparing alio SCT and auto SCT.7 lt 10 lt 24 lt 30-34 Among the earliest reports were small series by Milpied and colleagues7 and Bureo and coworkers.32 Chopra et al.30 communicated one of the first matched case-control studies. The way they reported their data enabled them to evaluate various NHL subtypes. For both lymphoblastic lymphoma and intermediate- and high-grade NHL, the benefit of a reduced treatment-related mortality in auto SCT was offset...
Mixed cellularity Hodgkins lymphoma
The mixed cellularity subtype is observed more frequently in patients with HIV disease, or in developing countries. It comprises 20-25 of classical HL cases, and is characterized by scattered Hodgkin's or Reed-Sternberg cells within a diffuse mixed inflammatory infiltrate without fibrosis.13 In contrast to NS HL, patients with MC HL are older median age 37 , predominantly male, and often with advanced-stage disease and B symptoms. Splenic involvement is reported in 30 of patients, bone marrow...
Histologic Transformation Of Follicular Lymphoma
Patients with a follicular lymphoma have a relatively constant risk over time of transforming into a more aggressive histology, most often a diffuse large B-cell lymphoma.16119120 The frequency of this occurrence varies among series from fewer than 20 16 to at least 30 .119 The difference among studies reflects a number of factors, including the duration of follow-up, the definition of what is called transformed lymphoma, and the method of surveillance. In studies in which patients had lymph...
Making The Diagnosis
On a routine complete blood count CBC , most patients with AML are anemic and thrombocytopenic.78 The white blood count is variable, with 20 of patients having white blood counts less than 5000 mm3 and 20 of patients with white blood counts greater than 100,000 mm3.78 High white blood counts and hyperleukocytosis are more common in the monocytic leukemias.36 79 Although blasts are usually present in the peripheral blood, a subset of patients present with aleukemic leukemia. A review of the...
Cytogenetic Remission
Cytogenetic remission is defined as a reduction in the number of identifiable Philadelphia Ph chromosomes by standard metaphase karyotypic analysis. The degree of reduction determines the completeness of remission, and this degree of reduction has prognostic significance with regard to survival. The importance of achieving a major or complete cytogenetic remission CCR is highlighted by the results of several randomized clinical trials comparing interferon-a to chemotherapy such as hydroxyurea....
Info Faz
33. Darby SC, Doll R, Gill SK, et al. Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 55 2 179-190, 1987. 34. Urowitz MB, Rider WD Myeloproliferative disorders in patients with rheumatoid arthritis treated with total body irradiation. Am J Med 78 1A 60-64, 1985. 35. Hempelmann LH, Hall WJ, Phillips M, et al. Neoplasms in persons treated with X-rays in infancy fourth survey in 20 years. J Natl Cancer Inst 55 3 519-530,...
Consolidation Therapy
The choice of appropriate postremission therapy will depend on the patient's risk of relapse, which can be estimated based on presenting WBC and platelet counts.4 APL patients in low- and intermediate-risk groups can generally be successfully consolidated with anthracyclines alone. In recent trials published by the PETHEMA and GIMEMA groups, relapse rates of patients in low and intermediate risk groups were less than 10 , following consolidation with anthracyclines plus ATRA or anthracycline...
Immunophenotype 1
The immunophenotype of lymphomas was first used in the Kiel classification for broad grouping of lymphomas into B-cell and T-cell types. With the inclusion of the NK-cell lymphomas into the T-cell group, this distinction remains a fundamental consideration in the REAL classification and serves as a primary step in the separation of the lymphomas into two broad groups. Within these broad groupings the detailed immunophenotype is useful in helping to define individual entities but in only a few...